← All stocks

Savara Inc

SVRA Net selling
CIK 0001160308 #2475 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$2.36M
$0.00 on a plan · $2.24M straight out of an exercise
Sold at will
$121.22K
1 of 2 sales
Net
−$2.36M
−$121.22K against sales at will

By person

13 insiders · 11 transactions
10.2×

Matthew Pauls holds 10.2 times base salary in stock. $6.75M of shares against $660.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Pauls last reported holding, valued at $5.68, the price Common Stock was last bought or sold at on the open market here, on 22 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lowrance David L
Chief Financial Officer
$2.24M (1) scheduled
−$2.24M
536,032
0.2609%
$3.05M
+56.6%
RAMSAY DAVID A
Director
$121.22K (1)
−$121.22K
2,533,642
1.23%
$14.39M
+13.9%
Pauls Matthew
CHIEF EXECUTIVE OFFICER
1,188,050
0.5782%
$6.75M
−7.4%
McCabe Kathleen R.
Chief Legal Officer
519,232
0.2527%
$2.95M
−7.0%
Erickson Anne
Chief Business Officer
371,712
0.1809%
$2.11M
+5.2%
Pratt Raymond Dennis
Chief Medical Officer
340,050
0.1655%
$1.93M
+9.7%
Lutz Robert Matthew
Chief Fin. & Operating Officer
328,977
0.1601%
$1.87M
+9.7%
McCracken Joseph S
Director
302,644
0.1473%
$1.72M
+58.6%
Wasfi Yasmine
Chief Medical Officer
168,008
0.0818%
$954.50K
+8.4%
Hawkins Richard J
Director
161,326
0.0785%
$916.54K
+357.8%
Elam Nevan C
Director
106,887
0.0520%
$607.26K
+375.1%
Parker Braden C.
Chief Commercial Officer
105,000
0.0511%
$596.54K
van Es-Johansson An
Director
102,500
0.0499%
$582.33K
+355.6%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 20
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,169,704
History held since 23 Jan 2017